Global Disrupted Greentech Feature

Amoéba featured in CNN Innovate programme

American Television Network Spotlights French Biotech Sensation for Reshaping Sustainable Crop Protection

In an international broadcast highlighting breakthroughs reshaping our world, the American television network Amoéba featured in CNN Innovate programme. The documentary spotlights the Chassieu-based green technology company for isolating a unique, natural strain of the Willaertia magna amoeba from thermal waters. Exploited at an unprecedented industrial scale, this unique amoeba-based biocontrol solution yields a highly effective biological fungicide, AXPERA, engineered to prevent aggressive fungal pathogens during wet weather without synthetic chemical dependency. Already heavily deployed in validation trials across prestigious European vineyards—such as Château Léoville Barton in Bordeaux—the biological alternative systematically bypasses regulatory copper caps and sulfur phytotoxicity to support sustainable viticulture amidst acute climate fluctuations.

CNN’s global program “Innovate” explores cutting-edge technological advancements, entrepreneurial business models, and visionary breakthroughs that work with nature, not against it, to shape a smarter, more sustainable planet.

The comprehensive multiplatform series traveled to Chassieu near Lyon, France, to feature Amoéba, a pioneering greentech company founded in 2010. Scientists there have successfully isolated a specific strain of the Willaertia magna C2c Maky amoeba from the local thermal waters of Aix-les-Bains, discovering its remarkable and powerful natural anti-fungal signaling mechanics.

Building directly upon this proprietary laboratory discovery, Amoéba has developed a world-first biological control solution. This natural amoeba-based biofungicide empowers crops to shield themselves from devastating fungal outbreaks, delivering consistent on-field efficacy particularly during prolonged wet weather cycles without trailing chemical toxicities.

This disruptive biocontrol strategy is already being actively adopted and evaluated by European growers. High-profile vineyards, including the prestigious Château Léoville Barton in Bordeaux, are utilizing the formulation as a sustainable, ecological alternative to traditional chemical treatments and copper-heavy crop sprays to address severe grapevine downy mildew challenges amid climate volatility.

By engineering a unique industrial cultivation process, Amoéba stands out as the only commercial entity globally capable of producing these beneficial amoebae in sufficient, stable volumes to create a commercially viable alternative to conventional chemical pesticides for international distribution.

The global broadcast validation from CNN aligns with major milestones for the firm, including winning the Bernard Blum Gold Medal for biocontrol innovation and a landmark gold medal at the SIVAL Innovation Competition. Backed by strategic partnerships with industry giants like Koppert and Syngenta to scale commercial distribution across the EU, the United Kingdom, and South America, the technology is stepping out of the lab directly into mainstream agricultural systems.

Amoéba S.A. – Corporate Communications & Investor Relations

Chassieu, Lyon, France | CNN Innovate Press Registry Briefing | June 2026 | amoeba-nature.com

Global Disrupted Greentech Feature

Amoéba featured in CNN Innovate programme

American Television Network Spotlights French Biotech Sensation for Reshaping Sustainable Crop Protection

In an international broadcast highlighting breakthroughs reshaping our world, the American television network Amoéba featured in CNN Innovate programme. The documentary spotlights the Chassieu-based green technology company for isolating a unique, natural strain of the Willaertia magna amoeba from thermal waters. Exploited at an unprecedented industrial scale, this unique amoeba-based biocontrol solution yields a highly effective biological fungicide, AXPERA, engineered to prevent aggressive fungal pathogens during wet weather without synthetic chemical dependency. Already heavily deployed in validation trials across prestigious European vineyards—such as Château Léoville Barton in Bordeaux—the biological alternative systematically bypasses regulatory copper caps and sulfur phytotoxicity to support sustainable viticulture amidst acute climate fluctuations.

CNN’s global program “Innovate” explores cutting-edge technological advancements, entrepreneurial business models, and visionary breakthroughs that work with nature, not against it, to shape a smarter, more sustainable planet.

The comprehensive multiplatform series traveled to Chassieu near Lyon, France, to feature Amoéba, a pioneering greentech company founded in 2010. Scientists there have successfully isolated a specific strain of the Willaertia magna C2c Maky amoeba from the local thermal waters of Aix-les-Bains, discovering its remarkable and powerful natural anti-fungal signaling mechanics.

Building directly upon this proprietary laboratory discovery, Amoéba has developed a world-first biological control solution. This natural amoeba-based biofungicide empowers crops to shield themselves from devastating fungal outbreaks, delivering consistent on-field efficacy particularly during prolonged wet weather cycles without trailing chemical toxicities.

This disruptive biocontrol strategy is already being actively adopted and evaluated by European growers. High-profile vineyards, including the prestigious Château Léoville Barton in Bordeaux, are utilizing the formulation as a sustainable, ecological alternative to traditional chemical treatments and copper-heavy crop sprays to address severe grapevine downy mildew challenges amid climate volatility.

By engineering a unique industrial cultivation process, Amoéba stands out as the only commercial entity globally capable of producing these beneficial amoebae in sufficient, stable volumes to create a commercially viable alternative to conventional chemical pesticides for international distribution.

The global broadcast validation from CNN aligns with major milestones for the firm, including winning the Bernard Blum Gold Medal for biocontrol innovation and a landmark gold medal at the SIVAL Innovation Competition. Backed by strategic partnerships with industry giants like Koppert and Syngenta to scale commercial distribution across the EU, the United Kingdom, and South America, the technology is stepping out of the lab directly into mainstream agricultural systems.

Amoéba S.A. – Corporate Communications & Investor Relations

Chassieu, Lyon, France | CNN Innovate Press Registry Briefing | June 2026 | amoeba-nature.com